cbdMD - YCBD Earnings per share for the trailing year

Public company logo of cbdMD Inc. (YCBD)

cbdMD, Inc. (YCBD) attracts leading wellness experts by providing them with career growth opportunities. The rolling annual change in net income per share on the GURU.Markets system chart illustrates profitability dynamics, where 94.40 reflects the latest metric value. Brand recognition and FDA oversight create barriers to entry for competitors. The company is currently optimizing expenses and updating its product range amid stagnation in the US CBD market.

cbdMD (YCBD): Earnings per share for the last twelve months from 02/11/2024 to 11/16/2026

cbdmd.com - analytical breakdowns and key metrics (YCBD)

- stock price and consensus target price:
- issuer market value details:
Fundamental company valuation:cbdMD Corp, YCBD
Manufactured product of cbdMD, Inc.

This indicator reflects the dynamics of net income per share over a rolling year, revealing the actual rate of capital growth. A positive trend confirms business efficiency, while sharp spikes often signal one-time adjustments. By analyzing the year-over-year change in EPS (TTM), an investor can assess income sustainability. For cbdMD, Inc. (YCBD), this is critical due to high competition in the CBD sector. The metric demonstrates the extent to which brand strength can protect margins amid FDA regulatory uncertainty.

Competitor analysis

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma, Inc)|Earnings per share for the trailing year CPIX|QNTM - Earnings per share for the last twelve months|FibroGen Corp (FGEN) - Net earnings per share for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Earnings per share for the last twelve months|Rani Therapeutics (RANI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Synergy CHC Corp.|Net earnings per one share for the last twelve months rallybio.com RLYB|Net earnings per share (EPS TTM) LEXX|PULM: Earnings per one share for the last 12 months|Pheton Holdings Ltd - Net earnings per share for the last 12 months|APM - Net earnings per share for the last 12 months|LYRA - Earnings per share for the last twelve months|Earnings per share for the trailing year IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRFX (PainReform Limited)|CYTO (Altamira Therapeutics Ltd.) - Net earnings per share (EPS TTM)|Lipella (LIPO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OPTN|Net earnings per share (EPS TTM) pieris.com (PIRS)|Earnings per share for the last twelve months Procaps Group Corp PROC|Petros Pharmaceuticals Inc - Earnings per share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months